Eczifine 50mg Tablet
Marketer
Syscutis Healthcare
Salt Composition
Azathioprine (50mg)
Overview Eczifine 50mg Tablet
Immunosuppressant medication, Eczifine 50mg tablets, is administered post-transplant (kidney, heart, liver, etc.) in conjunction with other drugs to prevent organ rejection. It also treats rheumatoid arthritis. Eczifine reduces the body's immune response, preventing the new organ's rejection. Dosage and frequency depend on the transplant type; strictly adhere to your physician's instructions. Take with food and consistently, even if feeling well, as discontinuation increases rejection risk. Potential side effects include nausea, appetite loss, and heightened bleeding risk. Immunosuppression increases infection susceptibility and cancer risk. Report concerning side effects immediately. Eczifine can cause birth defects and miscarriage; avoid use during pregnancy, planning pregnancy, or breastfeeding. Inform your doctor of infections, unusual bruising/bleeding, and all other medications you are taking, due to potential drug interactions. Regular blood tests will monitor blood cell counts.
Uses of Eczifine 50mg Tablet
Immunosuppression for transplant recipients and management of rheumatoid arthritis.
Major Benefits of Eczifine 50mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the 50mg Eczifine Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Eczifine 50mg Tablet:
- Decreased white blood cell count
- Increased bleeding tendency
- Nausea
- Infection
- Loss of appetite
How to use Eczifine 50mg Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Eczifine 50mg Tablet should be administered with a meal.
How Eczifine 50mg Tablet works:
Immunosuppressant Eczifine 50mg tablets subdue the body's immune response, thereby mitigating organ transplant rejection. This medication also inhibits inflammatory mediators, alleviating swelling, redness, and inflammation characteristic of specific arthritic conditions.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Eczifine 50mg Tablets may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Eczifine 50mg tablets during pregnancy is contraindicated due to confirmed risks to the fetus. In exceptional circumstances involving life-threatening conditions, a physician might prescribe it if the potential benefits outweigh the hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Eczifine 50mg Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Eczifine 50mg Tablet on driving ability is undetermined. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with impaired kidney function should use Eczifine 50mg Tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised. Eczifine 50mg Tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Eczifine 50mg Tablets cautiously, potentially requiring dosage modification under medical supervision. The medication is contraindicated in those with severe hepatic dysfunction. Consistent monitoring of liver function is recommended during treatment.
What if you forget to take Eczifine 50mg Tablet :
Should you forget a dose of Eczifine 50mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Eczifine 50mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Purine Nucleoside Analogs |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Action Class | Purine analog immunosuppressants |



